The ARF tumour suppressor gene encodes a small highly basic protein whose known functions are largely determined by the amino acids encoded within the first exon. In mammals, the protein incorporates additional residues specified by an alternative reading frame in the second exon of INK4a, but this arrangement does not apply to the chicken homologue. In exploring the intracellular localization of chicken p7 ARF , we found that while the FLAG-and HA-tagged versions localize in the nucleolus, in line with mammalian ARF, the GFP-tagged version is excluded from the nucleolus. Here we show that irrespective of the source or composition of the ARF fusion proteins, versions that accumulate in the nucleolus share the ability to bind to nucleophosmin (NPM). Depletion of NPM with siRNA results in the re-location and destabilization of nucleolar forms of ARF but has little effect on the location or stability of a nucleoplasmic form of ARF. Importantly, knockdown of endogenous NPM does not impair the ability of ARF to bind to MDM2 and stabilize p53. These findings support the view that nucleolar localization determines the stability of ARF but not its primary function.
Introduction
The ARF tumour suppressor is so named because, in mammals, the protein incorporates amino acids encoded by an alternative reading frame in the second exon of the adjacent INK4a gene (Quelle et al., 1995) . Although the genomic arrangement of the INK4a-ARF locus is broadly conserved in different species, the extent of the alternative reading frame varies. For example, the chicken orthologue of the protein, p7 ARF , has no contribution from exon 2 because the splicing of exon 1b to exon 2 occurs in a different register to that used in mammals, and translation terminates abruptly at the end of exon 1b (Kim et al., 2003) . We have therefore argued that the evolutionary pressure for exon sharing is unlikely to reflect the composition of the ARF protein and that its functional attributes are most likely specified by the sequences encoded by exon 1b (Gil and Peters, 2006) .
The best understood function of ARF is its ability to inhibit the ubiquitin ligase activity of MDM2 (Gil and Peters, 2006; Sherr, 2006) . In so doing, ARF stabilizes p53 resulting in the activation of p53 target genes, including that of the CDK inhibitor p21
CIP1
, and MDM2 itself. Importantly, these properties are retained in chicken p7 ARF (Kim et al., 2003) and in truncated versions of mammalian ARF from which the exon 2-derived sequences have been removed (Quelle et al., 1997; Stott et al., 1998; Zhang et al., 1998) . However, when visualized by immunofluorescence, human and mouse ARF are predominantly found in the nucleolus (Quelle et al., 1995; Stott et al., 1998) while both p53 and MDM2 are regarded as nucleoplasmic proteins that shuttle between the nucleus and cytoplasm Roth et al., 1998) . This has led to conflicting views about how proteins in different sub-nuclear compartments can interact, most of which suggest movement of MDM2 into the nucleolus (Tao and Levine, 1999; Weber et al., 1999 Weber et al., , 2000 Zhang and Xiong, 1999; Lohrum et al., 2000) . We have argued against this idea by showing that versions of human ARF that are excluded from the nucleolus remain capable of binding to MDM2 and stabilizing p53 (Llanos et al., 2001) . One such variant, a fusion protein containing the N-terminal 29 residues of human ARF linked to GFP (GFP/2-29), is inherently unstable, but can be stabilized if redirected to the nucleolus by addition of an unrelated basic motif (Llanos et al., 2001; Rodway et al., 2004) .
Despite the consistent links to MDM2 and p53, it is clear that ARF can have p53-independent functions and can interact with a plethora of cellular proteins (Sherr, 2006) . A notable example is nucleophosmin (also called NPM, B23, numatrin or NO38), which has been consistently identified in screens for ARF binding proteins in different laboratories, including our own (Itahana et al., 2003; Bertwistle et al., 2004; Brady et al., 2004; Korgaonkar et al., 2005) . NPM is an abundant, evolutionarily conserved protein that resides predominantly in the nucleolus and also shuttles between the nucleus and cytoplasm (Grisendi et al., 2006) . Among its attributes are protein chaperone and RNA processing activities, and it has been implicated in ribosome biogenesis, centrosome duplication and the maintenance of genome integrity. The gene is also a target of chromosomal translocations and frameshift mutations in human leukaemia (Grisendi et al., 2006) . Although a number of reports have suggested that ARF regulates NPM function (Itahana et al., 2003; Brady et al., 2004; Enomoto et al., 2006) , a more logical interpretation for which there is growing support would be that binding to NPM is responsible for the nucleolar accumulation and stability of ARF (Kuo et al., 2004; Korgaonkar et al., 2005) .
The studies described here were prompted by the observation that when fused to GFP, the chicken orthologue of ARF (ARF Ch ) is excluded from the nucleolus, reminiscent of the GFP/2-29 derivative of human ARF (Llanos et al., 2001) . In contrast, HA-and FLAG-tagged versions of ARF Ch accumulate in the nucleolus. We show that these disparities can be explained by the ability of the tagged proteins to associate with NPM Ch . Binding to NPM also explains the behaviour of nucleolar versus nucleoplasmic forms of human ARF. In particular, the ability to redirect GFP/2-29 to the nucleolus by adding basic motifs correlates with association with NPM. Furthermore, siRNA-mediated knockdown of NPM results in displacement of nucleolar forms of ARF into the nucleoplasm, accompanied by a significant loss in protein stability, whereas knockdown of NPM has little, if any, effect on the stability or location of GFP/2-29. Importantly, our results indicate that NPM knockdown has no effect on the ability of ARF variants to bind MDM2 and stabilize p53, in line with our previous assertion that ARF normally functions in the nucleoplasm (Llanos et al., 2001) .
Results

Intracellular localization of ARF Ch
We initially investigated the localization of chicken p7 ARF by transient expression of epitope-tagged versions of the protein (Kim et al., 2003) . When expressed in primary chicken embryo fibroblasts (CEFs), GFP-tagged p7 ARF (GFP/ARF Ch ) did not accumulate in the nucleolus but showed heterogeneous speckled staining of the nucleoplasm (Figure 1a) . In contrast, expression of human p14 ARF in CEFs resulted in typical nucleolar staining, detected by indirect immunofluorescence with an ARF monoclonal antibody and, when co-expressed, the human p14 ARF and GFP/ARF Ch proteins did not co-localize ( Figure 1a) .
Exclusion of full-length chicken p7 ARF from the nucleolus was surprising given that it contains the types of arginine-rich motifs that are believed to act as nucleolar localization signals. Moreover, GFP/ARF Ch showed a different staining pattern (both nucleolar and nucleoplasmic) when expressed in human U20S cells (Kim et al., 2003 (Figure 1d ).
Binding of ARF
Ch to nucleophosmin Reports of a direct interaction between mammalian ARF and NPM (Itahana et al., 2003; Bertwistle et al., 2004; Brady et (Figure 1a ). In the converse experiment, when GFP/ARF Ch was expressed in U20S cells, it could be co-precipitated with the endogenous human NPM (Figure 2c ), consistent with its partial association with the nucleolus in these cells (Kim et al., 2003) . However, when GFP/ARF Ch and NPM Ch were coexpressed in U20S cells, they did not appear to interact, whereas the FLAG/ARF Ch and HA/ARF Ch versions did associate with NPM Ch (Figure 2d ). Taken together, these data suggested that the nucleolar localization of the various fusion proteins correlated with their ability to associate with endogenous NPM in different contexts.
In interpreting these data, it is important to note that although the antibodies to chicken and human NPM were specific for their cognate proteins, the high degree of conservation between chicken and human NPM means that the two proteins are able to oligomerize if co-expressed (Supplementary Figure S1) . The fact that GFP/ARF Ch can co-precipitate with human NPM but not chicken NPM in U20S cells implies that ARF does not associate with the oligomeric forms of NPM. This would agree with reports that the ARF binding and oligomerization domains of NPM overlap (Enomoto et al., 2006) .
Binding to NPM determines the nucleolar localization of ARF To consolidate these ideas, we asked whether binding to NPM accounts for the sub-cellular localization of the various forms of human p14 ARF described in previous studies (summarized in Figure 3a ). When transiently expressed in U20S cells, full-length ARF (GFP/2-132) co-precipitated with NPM ( Figure 3b ) and the association was confirmed in the reciprocal precipitation (Figure 3c ). The 1-64/GFP and 65-132/GFP forms of ARF also associated with NPM, although the coprecipitation was much less efficient than with the fulllength protein. This agrees with immunostaining that suggests less avid association with the nucleolus. For reasons that are unclear, the association between 65-132/ GFP and NPM was only apparent when precipitated via NPM. Importantly, the GFP/2-29 version did not coprecipitate with NPM but addition of the 3 Â NLS motif from SV40 T-Ag restored binding (compare lanes 5 and 6). This implies that the association with NPM is not solely dependent on sequences from ARF.
To substantiate these findings, we repeated the analyses in clonal U20S lines that express comparable levels of GFP/2-29 and GFP/2-29 þ 3 Â NLS from a regulated promoter (Rodway et al., 2004) . Whereas the GFP/2-29 þ 3 Â NLS co-precipitated with the endogenous NPM, there was no detectable association with the GFP/2-29 protein (Figure 3d ).
Binding to NPM stabilizes ARF To further address the role of NPM, we used siRNA to knock down endogenous NPM in NARF6 cells and monitored the turnover of ARF following addition of cycloheximide (Figure 4a ). Under these conditions, depletion of NPM caused a reduction in the levels and stability of ARF. Additionally, NPM knockdown resulted in relocalization of ARF to the nucleoplasm, as determined by indirect immunofluorescence (Figure 4b ).
We applied the same approach to U20S cells that conditionally express the various GFP-fusion proteins described in Figure 3a . Importantly, depletion of NPM had little effect on the stability or location of GFP/2-29 (Figures 4c and d ) but caused the GFP/2-29 þ 3 Â NLS form of ARF to be displaced from the nucleolus accompanied by a significant loss in protein stability (Figures 4e and f) .
Nucleolar localization is not essential for ARF function
We previously showed that, despite its exclusion from the nucleolus and inherent instability, the GFP/2-29 form of ARF remains able to bind to MDM2 and stabilize p53 (Llanos et al., 2001; Rodway et al., 2004) . It was therefore important to establish whether the displacement of ARF following knockdown of NPM had a significant effect on ARF activity. To this end, NARF6 cells were transfected with NPM siRNA and following induction of ARF with IPTG, the association of p14 ARF with MDM2 and p53 was assessed by immunoprecipitation and immunoblotting. Importantly, 
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G F P / 2 -1 3 2 G F P / 1 -6 4 G F P / 6 5 -1 3 2 G F P / 2 -2 9 -G F P / 2 -2 9 Localization and function of ARF S Moulin et al reduction in the level and stability of p14 ARF had little, if any, impact on its ability to upregulate MDM2 and p53 (Figure 5a ) and the amounts of these proteins that coprecipitated with ARF ( Figure 5b ). This would be consistent with our previous study that suggested that a minor proportion of the total ARF is involved in the interaction with MDM2 (Llanos et al., 2001 ).
Discussion
The literature on ARF is heavily influenced by two assumptions, both of which are open to question. The first is that because ARF accumulates in the nucleolus when expressed at detectable levels, it must function in the nucleolus or by sequestering other proteins in this compartment. The second is that ARF modulates the activity of the many proteins with which it is reputed to interact. An alternative view, for which there is growing support, is that ARF operates in the nucleoplasm and that nucleolar association dictates the stability and availability of ARF (Llanos et al., 2001; Rodway et al., 2004; Korgaonkar et al., 2005) . The results we describe here reinforce this version of events and provide a mechanistic basis.
A major impetus for the study was the observation that a fusion protein comprising all 60 amino acids of ARF Ch linked to GFP appeared to be excluded from the nucleolus. The behaviour of GFP/ARF Ch therefore resembled that of the GFP/2-29 version of human ARF. It also confirmed that the sequences within ARF that confer nucleolar localization are context dependent. Fusion of the same sequences to either the HA or FLAG epitopes resulted in nucleolar localization, as did overexpression of the untagged p7 ARF (Figure 1 ). ARF Ch contains 22 arginine residues and previous reports have suggested that clusters of basic amino acids promote nucleolar localization. In human ARF, the relevant basic motifs are specified by both exons and each half of the protein, here represented by 1-64/GFP and 65-132/ GFP, can accumulate in the nucleolus, albeit less efficiently than the full-length protein (Zhang and Xiong, 1999; Lohrum et al., 2000; Rizos et al., 2000; Llanos et al., 2001) . However, the precise sequence of the basic motif may be immaterial, as GFP/2-29 can be redirected to the nucleolus by adding either a basic region from exon 2 of ARF or the 3 Â NLS motif from SV40 T-Ag (Llanos et al., 2001 ).
Although we have not determined which basic motifs interact with NPM, the common feature that discriminates between nucleolar and non-nucleolar forms of ARF is their ability to bind to NPM. The correlation holds irrespective of whether the proteins are functional. For example, in our hands 65-132/GFP is unable to bind to MDM2 or to stabilize p53 (Llanos et al., 2001; Clark et al., 2002) yet it co-precipitates with NPM ( Figure 3b ). Curiously, it proved difficult to demonstrate the reciprocal co-precipitation of NPM with 65-132/ GFP (Figure 3c ), which would be consistent with a previous report that a Myc-tagged version of 65-132 is unable to bind NPM, despite being expressed at high levels (Itahana et al., 2003) . The reason for this disparity is unclear, but we would argue that an association between 65-132/GFP and NPM is more in line with the localization and stability of the fusion protein. Interestingly the correlation between NPM binding and ARF localization also applied to the behaviour of ARF Ch in human cells and of human ARF expressed in CEFs (Kim et al., 2003 and Figure 1a) .
The pivotal role of NPM was further substantiated by using siRNA to reduce NPM expression. This resulted in the redistribution of all nucleolar forms of ARF into the nucleoplasm, accompanied by reduced stability (Figure 4) . Importantly, whereas nucleolar GFP/2-29 þ 3 Â NLS was displaced and destabilized, the nucleoplasmic GFP/ 2-29 version remained unaffected. These results are broadly consistent with previous reports, allowing for differences in the effectiveness of NPM knockdown (Kuo et al., 2004; Korgaonkar et al., 2005) . In this regard, the most persuasive evidence for the role of NPM comes from studies on NPM-knockout mice Grisendi et al., 2005) . At the cellular level, genetic ablation of NPM results in displacement of p19 ARF from the nucleolus accompanied by a dramatic loss in stability .
The issue that has not been fully resolved is whether NPM controls the activity of ARF, and if so under what circumstances. A confusing picture has emerged that may reflect the tradeoff between the availability and turnover of ARF when it is released into the nucleoplasm. If NPM levels are reduced, it could be argued that there would be more ARF in the nucleoplasm to bind to MDM2 and stabilize p53. Although there are published data that support this view of events (Korgaonkar et al., 2005) , the counter argument is that denying ARF access to the nucleolus would promote its destruction and undermine its impact on p53. In our hands, depletion of NPM caused a reduction in the total levels of ARF, because of reduced stability, but had little impact on the amount of ARF that associated with MDM2 and p53 ( Figure 5 ). This would be consistent with earlier immunodepletion experiments that suggested that only a fraction of the total ARF is involved in the interaction with MDM2 (Llanos et al., 2001) .
Similar arguments apply to the effects of NPM overexpression on ARF activity, complicated by the fact that only a fraction of the NPM in the cell is likely to engage ARF and that NPM can have ARF-independent effects on p53 (Colombo et al., 2002 den Besten et al., 2005; Korgaonkar et al., 2005) . However, there is at least one pathological setting where the status of NPM has a direct bearing on ARF. Approximately 35% of human acute myelogenous leukaemias have mutations in NPM that cause the protein to accumulate in the cytoplasm (Grisendi et al., 2006) . As a consequence, ARF is also redistributed to the cytoplasm where it is both unstable and unlikely to encounter its nucleoplasmic clients. Although the cells appear to have an attenuated p53 response, the effects are not dramatic presumably because the mutant NPM can oligomerize with the residual wild-type protein (den Besten et al., 2005; Colombo et al., 2006) .
There is general agreement that ARF becomes unstable when released from the nucleolus, but we know little of the machinery responsible for its rapid turnover. Different studies have suggested that ARF promotes ubiquitylation of NPM (Itahana et al., 2003) and that binding to NPM blocks the ubiquitylation of ARF (Kuo et al., 2004) . While the latter could explain why nucleoplasmic ARF is unstable when not bound to NPM, it cannot account for the instability of cytoplasmic ARF which ends up there because of its interaction with mutant NPM. It would clearly be instructive to generate a cytoplasmic form of ARF that is not associated with NPM, but this may not be possible with such a highly basic protein. However, a more pressing question is what causes the rapid turnover of nucleoplasmic ARF. Solving this problem might enable us to consolidate the idea that ARF normally functions in the nucleoplasm.
Materials and methods
Cells
U20S cells, NARF6 cells (Stott et al., 1998) and clonal lines of U20S that conditionally express the GFP/2-132, GFP/2-29, GFP/2-29 þ 3 Â NLS versions of human ARF (Rodway et al., 2004) were routinely cultured at 37 1C in Dulbecco-modified Eagles's medium (DMEM) supplemented with 10% fetal calf serum and antibiotics. Expression of ARF was induced by addition of either 1 mM IPTG (NARF6 cells) or 5 mg ml À1 doxycycline. Primary CEF were grown at 38.5 1C in DMEM supplemented with 10% heat-treated chicken serum. For transient transfections, cells plated at 90% confluency in 10-cm dishes were transfected with 20 mg plasmid DNA using Lipofectamine 2000, according to the manufacturer's instructions (Invitrogen Ltd., Paisley, UK).
Plasmids
Derivatives of the pEGFP-N1 vector (Takara Bio Europe/ Clontech, Saint-Germain-en-Laye, France) encoding the 1-64/GFP and 65-132/GFP variants of human ARF, and derivatives of the pEGFP-C3 vector (Clontech) encoding GFP/2-132, GFP/2-29 and GFP/2-29 þ 3 Â NLS were described previously (Llanos et al., 2001) . The analogous pEGFP-C3 based plasmid encoding chicken ARF (GFP/ARF Ch ) and a retrovirus vector encoding HA/ARF Ch have also been described (Kim et al., 2003 (Kim et al., , 2006 . The FLAG-tagged version was generated by transferring the ARF coding domain as an EcoRI-HindIII fragment into the pCMV-Tag2c vector, The chicken ARF coding sequences were also transferred as an EcoRI-XhoI fragment into the pcDNA3 vector (Invitrogen). The chicken NPM cDNA was cloned from primary CEF RNA using the Titan One Tube reverse transcriptase-PCR system (Roche Diagnostics Ltd., Lewes, DE, USA). It was then used as a template for PCR by using primers that introduced a BamHI and XhoI sites at the 5 0 and 3 0 ends, respectively, and transferred into pcDNA3.
Protein analyses
Cell lysates were prepared in NP40 lysis buffer (50 mM TrisHCl, pH 8.0, 150 mM NaCl, 1% Nonidet P40, 0.1 mM sodium fluoride, 100 mg ml À1 PMSF, and protease inhibitors). Samples containing 1 mg of protein were immunoprecipitated overnight at 4 1C using between 2 and 5 ml of antibody, depending on the antigen. The precipitated proteins were fractionated by SDS-PAGE in 12% gels and analysed as previously described (Stott et al., 1998) . Human p14 ARF was precipitated with the JR14 rabbit polyclonal antiserum and immunoblotted with the 4C6 monoclonal antibody (Llanos et al., 2001) . Proteins carrying the GFP epitope were immunoprecipitated and immunoblotted with the 4E12 and 3E1 monoclonal antibodies, respectively, both provided by the Cancer Research UK Monoclonal Antibody Production Service. Proteins carrying the HA epitope were detected with the 16B12 antibody (Covance Research Products, Cambridge, UK). Human NPM was detected with the FC-61991 antibody (Zymed, Paisley, UK) or the sc#6013 antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). A polyclonal antibody against amino acids 220-232 of chicken NPM was generated in the course of these studies. Chicken ARF was detected using the SK8 rabbit polyclonal antiserum (Kim et al., 2006) . Chicken p53 was detected using the HP64 mouse monoclonal antibody (supplied by T Soussi, Institut Curie, Paris, France). The antibody against MEK1/2 (#9122) was purchased from New England Biolabs and the b-actin antibody (CP01) was from Oncogene Science.
Protein turnover assays U20S cells expressing IPTG-or doxycycline-inducible ARF fusion proteins were plated at 60% confluency in six-well plates and transfected with a SMART pool siRNA against human NPM or a control nontargetting pool (Dharmacon, Erembodegem, Belgium). Transfection was performed with 40 nM of siRNA using Lipofectamine 2000. After 56 h, cells were treated with either 1 mM IPTG or 5 mg ml À1 doxycycline for 16 h to induce the expression of the ARF fusions proteins. Protein synthesis was blocked by addition of cycloheximide (20 mM) and cells were processed for immunoblotting after 0, 1, 2, 4, 6 and 8 h.
Immunofluorescence CEFs seeded at 90% confluency in six-well plates were transfected with a total of 3 mg plasmid DNA using Lipofectamine 2000 (Invitrogen). Cells were split onto coverslips 24 h after transfection. In the siRNA knockdown experiments, cells were split onto coverslips 48 h after transfection with a mock siRNA or NPM siRNA. Cells were fixed on coverslips for 15 min in PBS containing 4% paraformaldehyde. Fixed coverslips were then processed as previously described (Llanos et al., 2001) .
